Construction and Verification of a Hypoxia-Related 4-lncRNA Model for Prediction of Breast Cancer

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.
   PubMed Web of Science ®Google Scholar
• Schoppmann SF, Bayer G, Aumayr K, et al. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg. 2004;240(2):306–312.
   PubMed Web of Science ®Google Scholar
• Spizzo G, Gastl G, Wolf D, et al. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival. Br J Cancer. 2003;88(4):574–578.
   PubMed Web of Science ®Google Scholar
• Spizzo G, Obrist P, Ensinger C, et al. Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer. Int J Cancer. 2002;98(6):883–888.
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci. 2012;33(4):207–214.
   PubMed Web of Science ®Google Scholar
• Liang X, Arullampalam P, Yang Z, et al. Hypoxia enhances endothelial intercellular adhesion molecule 1 protein level through upregulation of arginase type ii and mitochondrial oxidative stress. Front Physiol. 2019;10:1003.
   PubMed Web of Science ®Google Scholar
• Harris AL. Hypoxia–a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2(1):38–47.
   PubMed Web of Science ®Google Scholar
• Schito L, Rey S, Tafani M, et al. Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells. Proc Natl Acad Sci U S A. 2012;109(40):E2707–16.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wong CC, Wei H, et al. HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene. 2012;31(14):1757–1770.
   PubMed Web of Science ®Google Scholar
• Wong CC, Zhang H, Gilkes DM, et al. Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis. J Mol Med (Berl). 2012;90(7):803–815.
   PubMed Web of Science ®Google Scholar
• Xiang L, Gilkes DM, Chaturvedi P, et al. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer. J Mol Med (Berl). 2014;92(2):151–164.
   PubMed Web of Science ®Google Scholar
• Semenza GL. The hypoxic tumor microenvironment: a driving force for breast cancer progression. Biochim Biophys Acta. 2016;1863(3):382–391.
   PubMed Web of Science ®Google Scholar
• Jathar S, Kumar V, Srivastava J, et al. Technological developments in lncRNA biology. Adv Exp Med Biol. 2017;1008:283–323.
   PubMed Web of Science ®Google Scholar
• Kapranov P, Cheng J, Dike S, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. 2007;316(5830):1484–1488.
   PubMed Web of Science ®Google Scholar
• Deveson IW, Hardwick SA, Mercer TR, et al. The dimensions, dynamics, and relevance of the mammalian noncoding transcriptome. Trends Genet. 2017;33(7):464–478.
   PubMed Web of Science ®Google Scholar
• Chakravarty D, Sboner A, Nair SS, et al. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat Commun. 2014;5:5383.
   PubMed Web of Science ®Google Scholar
• Jakubik D, Fitas A, Eyileten C, et al. MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics. Cardiovasc Diabetol. 2021;20(1):55.
   PubMed Web of Science ®Google Scholar
• Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21(6):354–361.
   PubMed Web of Science ®Google Scholar
• Flemban A, Qualtrough D. The potential role of hedgehog signaling in the luminal/basal phenotype of breast epithelia and in breast cancer invasion and metastasis. Cancers (Basel). 2015;7(3):1863–1884.
   PubMed Web of Science ®Google Scholar
• Chen Q, Hu L, Chen K. Construction of a nomogram based on a hypoxia-related lncrna signature to improve the prediction of gastric cancer prognosis. Front Genet. 2020;11:570325.
   PubMed Web of Science ®Google Scholar
• Zhang F, Wang X, Hu H, et al. A hypoxia related long non-coding RNA signature could accurately predict survival outcomes in patients with bladder cancer. Bioengineered. 2021;12(1):3802–3823.
   PubMed Web of Science ®Google Scholar
• Zhang H, Qin C, Liu HW, et al. An effective hypoxia-related long non-coding RNAs assessment model for prognosis of clear cell renal carcinoma. Front Oncol. 2021;11:616722.
   PubMed Web of Science ®Google Scholar
• Uhlen M, Zhang C, Lee S, et al. A pathology atlas of the human cancer transcriptome. Science. 2017;357:6352.
   Web of Science ®Google Scholar
• Elkin EB, Klem ML, Gonzales AM, et al. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin’s lymphoma: a multi-institutional, matched cohort study. J Clin Oncol. 2011;29(18):2466–2473.
   PubMed Web of Science ®Google Scholar
• Laasik M, Hynninen J, Forsback S, et al. The feasibility of [(18)F]EF5-PET/CT to image hypoxia in ovarian tumors: a clinical study. EJNMMI Res. 2020;10(1):103.
   PubMed Web of Science ®Google Scholar
• Chen WL, Jin X, Wang M, et al. GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK/mTORC1 signaling. JCI Insight. 2020;5:3.
   Web of Science ®Google Scholar
• Zhou F, Shen F, Zheng Z, et al. The LncRNA XIRP2-AS1 predicts favorable prognosis in colon cancer. Onco Targets Ther. 2019;12:5767–5778.
   PubMed Web of Science ®Google Scholar
• Sun W, Zu Y, Fu X, et al. Knockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy. Oncol Rep. 2017;38(6):3347–3354.
   PubMed Web of Science ®Google Scholar
• Wu D, Li Y, Zhang H, et al. Knockdown of Lncrna PVT1 enhances radiosensitivity in non-small cell lung cancer by sponging Mir-195. Cell Physiol Biochem. 2017;42(6):2453–2466.
   PubMedGoogle Scholar
• Zeng Z, Xu FY, Zheng H, et al. LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1alpha. Theranostics. 2019;9(18):5298–5314.
   PubMed Web of Science ®Google Scholar
• Chen KC, Chen CR, Chen CY, et al. Bicalutamide elicits renal damage by causing mitochondrial dysfunction via ROS damage and upregulation of HIF-1. Int J Mol Sci. 2020;21:9.
   Web of Science ®Google Scholar
• Wang C, Han C, Zhang Y, et al. LncRNA PVT1 regulate expression of HIF1alpha via functioning as ceRNA for miR199a5p in nonsmall cell lung cancer under hypoxia. Mol Med Rep. 2018;17(1):1105–1110.
   PubMed Web of Science ®Google Scholar
• Wang X, Li L, Zhao K, et al. A novel LncRNA HITT forms a regulatory loop with HIF-1alpha to modulate angiogenesis and tumor growth. Cell Death Differ. 2020;27(4):1431–1446.
   PubMed Web of Science ®Google Scholar
• Betts JA, Moradi Marjaneh M, Al-Ejeh F, et al. Long noncoding RNAs CUPID1 and CUPID2 mediate breast cancer risk at 11q13 by modulating the response to DNA damage. Am J Hum Genet. 2017;101(2):255–266.
   PubMed Web of Science ®Google Scholar
• Sun M, Gadad SS, Kim DS, et al. Discovery, annotation, and functional analysis of long noncoding RNAs controlling cell-cycle gene expression and proliferation in breast cancer cells. Mol Cell. 2015;59(4):698–711.
   PubMed Web of Science ®Google Scholar
• Heilmann K, Toth R, Bossmann C, et al. Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer. Oncogene. 2017;36(46):6446–6461.
   PubMed Web of Science ®Google Scholar
• Veeratterapillay R, Simren R, El-Sherif A, et al. Accuracy of the revised 2010 TNM classification in predicting the prognosis of patients treated for renal cell cancer in the north east of England. J Clin Pathol. 2012;65(4):367–371.
   PubMed Web of Science ®Google Scholar
• Janku F. Tumor heterogeneity in the clinic: is it a real problem? Ther Adv Med Oncol. 2014;6(2):43–51.
   PubMed Web of Science ®Google Scholar
• Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature. 2013;501(7467):328–337.
   PubMed Web of Science ®Google Scholar
• Aoki M, Shoji H, Kashiro A, et al. Prospects for comprehensive analyses of circulating tumor cells in tumor biology. Cancers (Basel). 2020;12:5.
   Web of Science ®Google Scholar
• Lai J, Chen B, Zhang G, et al. Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signature. J Transl Med. 2020;18(1):416.
   PubMed Web of Science ®Google Scholar
• Ye J, Wu S, Pan S, et al. Risk scoring based on expression of long noncoding RNAs can effectively predict survival in hepatocellular carcinoma patients with or without fibrosis. Oncol Rep. 2020;43(5):1451–1466.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zheng P, Li Z, et al. The somatic mutation landscape and RNA prognostic markers in stomach adenocarcinoma. Onco Targets Ther. 2020;13:7735–7746.
   PubMed Web of Science ®Google Scholar
• Tan YE, Xing Y, Ran BL, et al. LINC01235-TWIST2 feedback loop facilitates epithelial-mesenchymal transition in gastric cancer by inhibiting THBS2. Aging (Albany NY). 2020;12(24):25060–25075.
   PubMedGoogle Scholar
• Vishnubalaji R, Shaath H, Elkord E, et al. Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as non-favorable prognostic biomarker regulated by TGFbeta and focal adhesion kinase (FAK) signaling. Cell Death Discov. 2019;5:109.
   PubMed Web of Science ®Google Scholar
• Pan YF, Su T, Chen LD, et al. Differential expression of genes in HepG2 cells caused by UC001kfo RNAi as shown by RNA-seq. J Huazhong Univ Sci Technolog Med Sci. 2017;37(4):510–515.
   PubMedGoogle Scholar
• Ying K, Wang L, Long G, et al. ACTA2-AS1 suppresses lung adenocarcinoma progression via sequestering miR-378a-3p and miR-4428 to elevate SOX7 expression. Cell Biol Int. 2020;44(12):2438–2449.
   PubMed Web of Science ®Google Scholar
• Luo L, Wang M, Li X, et al. A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression. Cancer Cell Int. 2020;20:372.
   PubMed Web of Science ®Google Scholar
• Li N, Zhan X. Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer. EPMA J. 2019;10(3):273–290.
   PubMed Web of Science ®Google Scholar